Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-26-074310
Filing Date
2026-07-01
Accepted
2026-07-01 16:30:51
Documents
127
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0295524-20f_chinasxt.htm   iXBRL 20-F 2188399
2 DESCRIPTION OF REGISTERED SECURITIES ea029552401ex2-2.htm EX-2.2 134660
3 LIST OF SUBSIDIARIES AND CONSOLIDATED VARIABLE INTEREST ENTITIES ea029552401ex8-1.htm EX-8.1 6034
4 CERTIFICATION ea029552401ex12-1.htm EX-12.1 11984
5 CERTIFICATION ea029552401ex12-2.htm EX-12.2 11824
6 CERTIFICATION ea029552401ex13-1.htm EX-13.1 4206
7 CONSENT OF ENROME LLP ea029552401ex23-1.htm EX-23.1 5561
8 CONSENT OF ZH CPA, LLC ea029552401ex23-2.htm EX-23.2 5222
9 GRAPHIC ea029552401_img1.jpg GRAPHIC 44092
10 GRAPHIC ea029552401_img2.jpg GRAPHIC 18508
11 GRAPHIC ea029552401_img3.jpg GRAPHIC 12892
12 GRAPHIC ea029552401_img4.jpg GRAPHIC 26093
13 GRAPHIC ea029552401_img5.jpg GRAPHIC 39113
14 GRAPHIC ea029552401_ex23-1img1.jpg GRAPHIC 3502
15 GRAPHIC ea029552401_ex23-1img2.jpg GRAPHIC 2844
16 GRAPHIC ea029552401_ex23-2img1.jpg GRAPHIC 5979
  Complete submission text file 0001213900-26-074310.txt   10154494

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE sxtc-20260331.xsd EX-101.SCH 84697
18 XBRL CALCULATION FILE sxtc-20260331_cal.xml EX-101.CAL 82667
19 XBRL DEFINITION FILE sxtc-20260331_def.xml EX-101.DEF 319847
20 XBRL LABEL FILE sxtc-20260331_lab.xml EX-101.LAB 549936
21 XBRL PRESENTATION FILE sxtc-20260331_pre.xml EX-101.PRE 499414
131 EXTRACTED XBRL INSTANCE DOCUMENT ea0295524-20f_chinasxt_htm.xml XML 1141095
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China
Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-38773 | Film No.: 261145710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)